The Plasma Derivatives Act Article 9
Medical institutions and physicians shall give preference to the use of plasma derivatives made from blood donated domestically and provide patients with prescription information on such usage.To respect patients’ right to choose the preparations to be used, the use of preparations manufactured by other materials, methods or genetic engineering is not restricted by the preceding paragraph.
中文原文 血液製劑條例第9條
醫療機構、醫師使用血液製劑時，應優先使用國內捐血製造之血液製劑，並提供病人血液製劑之用藥資訊。
為尊重病人使用之意願，以其他原料、方法或基因工程所製成之製劑，使用時不受前項規定之限制。
為尊重病人使用之意願，以其他原料、方法或基因工程所製成之製劑，使用時不受前項規定之限制。